These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38380944)

  • 1. Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.
    van Toledo DE; Bleijenberg AG; Venema A; de Wit MJ; van Eeden S; Meijer GA; Carvalho B; Dekker E; Henneman P; IJspeert JE; van Noesel CJ
    J Pathol Clin Res; 2024 Mar; 10(2):e348. PubMed ID: 38380944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.
    Bleijenberg AG; IJspeert JE; Mulder JB; Drillenburg P; Stel HV; Lodder EM; Carvalho B; Jansen J; Meijer G; van Eeden S; Dekker E; van Noesel CJ
    J Pathol; 2022 Jun; 257(2):239-249. PubMed ID: 35143042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of hMLH1 promoter methylation and protein expression status in the serrated neoplasia pathway.
    Lee EJ; Chun SM; Kim MJ; Jang SJ; Kim do S; Lee DH; Youk EG
    Histopathology; 2016 Aug; 69(2):198-210. PubMed ID: 26713412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
    World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
    Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
    BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.
    Murakami T; Kurosawa T; Fukushima H; Shibuya T; Yao T; Nagahara A
    Dig Endosc; 2022 Sep; 34(6):1096-1109. PubMed ID: 35352394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving pathologic concepts of serrated lesions of the colorectum.
    Kim JH; Kang GH
    J Pathol Transl Med; 2020 Jul; 54(4):276-289. PubMed ID: 32580537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
    Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
    Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas.
    Aoki H; Takasawa A; Yamamoto E; Niinuma T; Yamano HO; Harada T; Kubo T; Yorozu A; Kitajima H; Ishiguro K; Kai M; Katanuma A; Shinohara T; Nakase H; Sugai T; Osanai M; Suzuki H
    BMC Gastroenterol; 2024 Mar; 24(1):91. PubMed ID: 38429655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas.
    Patai ÁV; Barták BK; Péterfia B; Micsik T; Horváth R; Sumánszki C; Péter Z; Patai Á; Valcz G; Kalmár A; Tóth K; Krenács T; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):589-594. PubMed ID: 27896617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal carcinoma occurring via the adenoma-carcinoma pathway in patients with serrated polyposis syndrome.
    Nakamura F; Sato Y; Okamoto K; Fujino Y; Mitsui Y; Kagemoto K; Kawaguchi T; Miyamoto H; Muguruma N; Sonoda T; Tsuneyama K; Takayama T
    J Gastroenterol; 2022 Apr; 57(4):286-299. PubMed ID: 35194694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of sessile serrated adenomas with dysplasia including intramucosal adenocarcinoma and colorectal carcinoma with a microsatellite instability phenotype.
    Sugai T; Uesugi N; Osakabe M; Yao T; Yanagawa N; Ajioka Y
    Hum Pathol; 2024 Mar; 145():9-15. PubMed ID: 38218351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Externalization of saw-tooth architecture in small serrated polyps implies the presence of methylation of IGFBP7.
    Kaji E; Uraoka T; Kato J; Hiraoka S; Suzuki H; Akita M; Saito S; Tanaka T; Ohara N; Yamamoto K
    Dig Dis Sci; 2012 May; 57(5):1261-70. PubMed ID: 22173745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.
    Liu C; Fennell LJ; Bettington ML; Walker NI; Dwine J; Leggett BA; Whitehall VLJ
    Clin Epigenetics; 2019 Jun; 11(1):90. PubMed ID: 31200767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.